spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Lupin 

 HSMN NewsFeed - 7 Oct 2021
Tris Pharma(R) Hires Seasoned Business Development Executive
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 10 Nov 2020
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Aug 2020
Lupin Presents Phase 3 Data for Solosec(R) (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2020
Mylan and Lupin Receive European Marketing Authorization for Nepexto(R), Biosimilar Etanercept
Biopharmaceuticals Generics Regulatory
 HSMN NewsFeed - 28 Jan 2019
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2018
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 28 Jun 2018
Lupin and Mylan Partner to Commercialize Enbrel(R) (Etanercept) Biosimilar
Biopharmaceuticals Generics
 HSMN NewsFeed - 23 Mar 2018
Lannett Strengthens, Augments Management Team
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 29 Sep 2016
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 2 Feb 2016
Lupin Launches Generic Glumetza(R) HCI ER Tablets in the US
Biopharmaceuticals Generics Endocrinology Product Launch
 HSMN NewsFeed - 5 Nov 2015
Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2015
BioBlast Pharma Augments Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2014
Lupin Appoints Theresa Stevens as Chief Corporate Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Sep 2013
Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of Savella(R) Patents
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Mar 2013
United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex(R) (celecoxib capsules)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 22 Feb 2013
Lupin Receives FDA Approval for New Drug Application for SUPRAX(R) Oral Suspension, 500 mg/5mL
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 May 2010
Lupino Joins SunTech Medical
Devices Monitoring Personnel
 HSMN NewsFeed - 8 Feb 2010
Lupin Receives FDA Approval for Amlodipine/Benazepril Capsules
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 28 Jan 2010
Lupin Receives U.S. FDA Approval For Perindopril Erbumine Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Jan 2010
Lupin Receives US FDA Tentative Approval for Memantine HCl Tablets
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 30 Nov 2009
Depomed Files Patent Infringement Lawsuit Against Lupin Limited
Biopharmaceuticals Generics Litigation FDA
 HSMN NewsFeed - 10 Nov 2009
Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Jan 2009
Lupin is Granted USFDA Approval for Levetiracetam Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Aug 2008
Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus(R) Brand in the US - Extends its Franchise with Pediatricians
Biopharmaceuticals
 HSMN NewsFeed - 30 May 2008
Lupin Receives USFDA Approval for Topiramate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Jul 2007
Lupin Receives Final Approval for Amlodipine Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 15 May 2007
Lupin Receives US FDA Approval for Simvastatin Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 May 2007
Lupin Announces Final FDA Approval of Cefdinir for Oral Suspension, 250 mg/5 mL, Launches Entire Product Family
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Apr 2007
Lupin Receives US FDA Approval for Novel Formulation of Suprax(R) Suspension
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Jan 2007
Lupin Pharmaceuticals Announces Tentative Approval of Generic ZOLOFT(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 Sep 2006
Lupin Announces Approval of Ceftriaxone 10G Vials
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Jul 2006
King Pharmaceuticals Reports Federal Court Upholds Validity of Altace(R) Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 26 Jun 2006
Lupin Receives Final Approval for Quinapril Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 May 2006
Lupin Announces Final FDA Approval of Cefdinir Capsules
Biopharmaceuticals Generics FDA
Return to NewsFeed  

 Additional items found! 7

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 7 additional stories matching:
Lupin
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.